We are Svar Life Science!

We deliver answers you can trust, from discovery to diagnosis.

Contact us

iLite® Cell-based Solutions

Solutions based on the iLite reporter gene technology, modified and adapted for applications during the whole drug development continuum as well as for monitoring of biological drugs.

Complement System Solutions

The Svar Complement Portfolio consist of simple and objective assays that provide a complete picture of the complement system by assessing the functionality and activity of complement. 

Wieslab Bioanalytical Services

Specialist bioanalytical service laboratory centered on large molecules (biologics and biosimilars). CRO services according to  GCP, GLP, and ISO 17025 with versatile solutions for the whole drug development continuum.

Calprotectin Solutions (Calpro)

High quality total solutions for Calprotectin analysis. From fully automated systems, to home monitoring of patients with IBD.
Opening hours – Summer 2019
"Cell-line of the month" - IL-23
Why do colony stimulating factors have unique biological roles offering therapeutic benefits?
Introducing iLite Granulocyte Colony-Stimulating Factor (G-CSF) Responsive Cell Line
Introducing iLite® Assay Ready Cells for IL-2 and IL-6
Why are interleukins interesting targets in biological drug compounds?
Cell line of the month - FGF21
Introducing Complement TCC - The newest addition to the Svar Life Science Complement range
New tests & updates to our 2019 Diagnostic Test Portfolio
Website Launch

Wieslab Request forms

Our diagnostic service laboratory offer clinical testing specialized in autoimmunity assessment. Our request forms available for Autoimmune Diagnostics, Neurology testing and Monitoring of Biopharmaceuticals that list the test panels and individual markers currently available. 

Please note that the forms can be downloaded, are interactive and can be filled out electronically.


”We provide life science customers high quality solutions, the best analytical technologies for drug development and clinical research and work to establish practical platforms for routine diagnosis”